Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

RBC Capital Downgrades Outset Medical to Sector Perform, Lowers Price Target to $6

Author: Benzinga Newsdesk | January 12, 2024 07:20am
RBC Capital analyst Shagun Singh downgrades Outset Medical (NASDAQ:OM) from Outperform to Sector Perform and lowers the price target from $14 to $6.

Posted In: OM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist